Compared with those in NAFLD mice, FAS and SREBP-1 levels in NAFLD+AGL9 mice were significantly decreased (p < 0.05) (Figure 4). The gene discussed is FAS; the disease is metabolic dysfunction-associated steatotic liver disease.